Efficacy and safety of a bortezomib and reduced‐intensity cytarabine‐based protocol, TMC ALLR1, for relapsed childhood ALL in India-Reference-Cited by-同舟云学术

Efficacy and safety of a bortezomib and reduced‐intensity cytarabine‐based protocol, TMC ALLR1, for relapsed childhood ALL in India

Published:2019-06-05 Issue:6 Volume:186 Page:861-865
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Roy Prakriti¹,Islam Rubina¹,Saha Debparna¹,Gogoi Manash¹,Kumar Mishra Deepak²,Arora Neeraj²,Parihar Mayur²,Krishnan Shekhar¹³,Saha Vaskar¹³^ORCID

Affiliation:

1. Department of Paediatric Haematology Oncology Tata Translational Cancer Research Centre, Tata Medical Centre Kolkata India

2. Department of Cytogenetics and Laboratory Haematology Tata Medical Centre Kolkata India

3. Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health University of Manchester Manchester UK

Funder

The Wellcome Trust DBT India Alliance

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16005

Reference15 articles.

1. The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood

2. Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

3. Determinants of Treatment Abandonment in Childhood Cancer: Results from a Global Survey

4. FxCycle based ploidy correlates with cytogenetic ploidy in B‐cell acute lymphoblastic leukemia and is able to detect the aneuploid minimal residual disease clone;Gupta N.;Cytometry Part B: Clinical Cytometry,2019

5. Bortezomib reinduction chemotherapy in high‐risk ALL in first relapse: a report from the Children's Oncology Group

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease‐burden‐adapted immunotherapy protocol for primary refractory or high‐risk relapsed pediatric acute lymphoblastic leukemia;HemaSphere;2024-07-29

2. FLAG with Bortezomib Salvage Therapy in Relapsed/Refractory Childhood Leukemia—A Reliable Bridge to Transplantation with Limited Toxicity;South Asian Journal of Cancer;2024-04-11

3. Treating relapsed B cell-precursor ALL in children with a setting-adapted mitoxantrone-based intensive chemotherapy protocol (TMH rALL-18 PROTOCOL) — experience from Tata Memorial Hospital, India;Annals of Hematology;2023-07-21

4. What happens to children with acute lymphoblastic leukemia in low- and middle-income countries after relapse? A single-center experience from India;Pediatric Hematology and Oncology;2023-07-04

5. Relapsed Acute Lymphoblastic Leukemia;Indian Journal of Pediatrics;2023-06-21